Dr. Michel Aubé, ETST’s CEO & CSO continuos , â

Dr. Michel Aubé, ETST’s CEO & CSO continuos , “With my team of scientific researchers and laboratory resources in Canada, ETST now has the scientific expertise and the clinical support needed to develop these Cannabis CBD based products for the health benefit of people worldwide. Having several additional unique, advanced CBD nutraceutical products on the market will grant ETST a competitive advantage, thus consequently solidifying its leadership position in that market. Our two planned CBD-Based Pharmaceutical drugs will allow us to enter a new industry, making us one of the very few companies in this arena.

https://globenewswire.com/news-release/2016/1...nt-IP.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!